Literature DB >> 9683266

Physical association between CD155 and CD44 in human monocytes.

M S Freistadt1, K E Eberle.   

Abstract

Regulation of CD44-mediated binding to hyaluronan is critical in normal and diseased immune cell function. In earlier work by others (Shepley and Racaniello, J. Virol., 68, 1301 1309), anti-CD44 mAb blocked poliovirus binding to CD155 (the poliovirus receptor) in HeLa cells, suggesting that CD155 and CD44 may be physically associated. Here, we present evidence that CD155 and CD44 are physically associated in human monocytes. In co-modulation experiments in U937 monocytic cells, CD155 and CD44 reciprocally co-modulated. In primary human monocytes, CD 155 syn-capped with CD44. In immunofluorescence flow cytometric experiments, anti CD44 mAb inhibited up to 94% of binding by anti-CD155 mAb which blocks poliovirus binding to CD155. This inhibition was specific for CD155. Culturing monocytes increased the extent of inhibition. In addition, mAb against PRR2, a novel molecule that is related to CD 155, was inhibited by anti-CD44 in a dose-dependent manner, but not by anti-CD14. These data support the interpretation that CD155 (and related proteins) are physically associated with CD44 on monocyte cell surfaces. Although the current study does not address functional significance, we speculate that this interaction may have a role in regulating monocyte CD44 ligand binding which may be critical in pathological processes such as tumor metastasis and arthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9683266     DOI: 10.1016/s0161-5890(98)00003-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

1.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

2.  Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.

Authors:  Anne-Sophie Gosselin; Yannick Simonin; Florence Guivel-Benhassine; Vincent Rincheval; Jean-Luc Vayssière; Bernard Mignotte; Florence Colbère-Garapin; Thérèse Couderc; Bruno Blondel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 3.  Neutrophil and monocyte recruitment by PECAM, CD99, and other molecules via the LBRC.

Authors:  David P Sullivan; William A Muller
Journal:  Semin Immunopathol       Date:  2013-12-12       Impact factor: 9.623

Review 4.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

5.  Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99.

Authors:  David P Sullivan; Michael A Seidman; William A Muller
Journal:  Am J Pathol       Date:  2013-01-18       Impact factor: 4.307

6.  CD44 Promotes intoxication by the clostridial iota-family toxins.

Authors:  Darran J Wigelsworth; Gordon Ruthel; Leonie Schnell; Peter Herrlich; Josip Blonder; Timothy D Veenstra; Robert J Carman; Tracy D Wilkins; Guy Tran Van Nhieu; Serge Pauillac; Maryse Gibert; Nathalie Sauvonnet; Bradley G Stiles; Michel R Popoff; Holger Barth
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?

Authors:  Zaynah Maherally; James R Smith; Qian An; Geoffrey J Pilkington
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 8.  Enter the kill zone: initiation of death signaling during virus entry.

Authors:  Pranav Danthi
Journal:  Virology       Date:  2011-01-22       Impact factor: 3.616

9.  CD155/PVR plays a key role in cell motility during tumor cell invasion and migration.

Authors:  Kevin E Sloan; Brenda K Eustace; Jean K Stewart; Carol Zehetmeier; Claudia Torella; Marina Simeone; Jennifer E Roy; Christine Unger; David N Louis; Leodevico L Ilag; Daniel G Jay
Journal:  BMC Cancer       Date:  2004-10-07       Impact factor: 4.430

Review 10.  Coming of Age: CD96 Emerges as Modulator of Immune Responses.

Authors:  Hristo Georgiev; Inga Ravens; Georgia Papadogianni; Günter Bernhardt
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.